Randomized control clinical trial to determine the effect of kutajadi taila in the management of kikwis with special reference to striae gravidarum.

Randomized controlled clinical trial to determine the effect of kutajadi taila in the management of kikwis W.S.R to striae gravidarum. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/089706

Enrollment

Registered

2025-06-27

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients whose informed written consent has been taken and sensitivity test has been done. 2.Primigravida in third trimester(completed 24 weeks)having signs and symptoms of kikwis such as kandu, vidah, twakbheda,vaivarnya,rekhaswaroop twak sankoch.

Exclusion criteria

Exclusion criteria: 1.Multi gravida and multi para with previous scar marks. 2.Disease other than kikwis. 3.K/C/O GDM, pre eclampsia, eclampsia, 4.polyhydramnios, bad obstetric history. 5.Multiple pregnancy like twin or triplet pregnancy. Patient having systemic or chronic illness.

Design outcomes

Primary

Measure	Time frame
Improvement in striae gravidarum.Timepoint: In 12 weeks of local application of taila.	—

Secondary

Measure	Time frame
Decrease in length, breadth, no.of lesions.Timepoint: In 12 weeks of local application of taila.	—

Countries

India

Contacts

Public ContactDr Sonal wagh

SST Ayurved Mahavidyalaya,Sangamner

sonaldere1@gmail.com9960212188

Outcome results